Yunnan Cancer Hospital clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-30 | NCT07907354 Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and HER2-Low Advanced… | Phase 2 | Not Yet Recruiting |
| 2026-10-21 | NCT07886320 Adapalene Gel for Acute Radiation-Induced Skin Injury | Early Phase 1 | Recruiting |
Active trials by phase
| Early Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 2 |
Not charted: 19 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Breast Cancer (9) · Bladder Cancer (3) · Gastric Cancer (3) · Colorectal Cancer (2) · Esophageal Cancer (1) · Head & Neck Cancer (1) · HER2-Positive Cancer (1) · Liver Cancer (1) · Lung Cancer (1) · NASH / MASH (1)
Get alerts when Yunnan Cancer Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.